Kos Pharmaceuticals to Present at Deutsche Bank Small Cap Growth Conference

Strategic Insights -

Kos Pharmaceuticals, a fully integrated specialty pharmaceutical company, announced that its President and Chief Executive Officer, Adrian Adams, will present at the Deutsche Bank Small Cap Growth Conference in Naples, Florida. The presentation will take place on February 16, 2006, and interested parties can access the webcast information through Kos' website. As a company focused on developing and commercializing proprietary prescription products, Kos is engaged in the reformulation of existing pharmaceutical products to improve safety, efficacy, and patient compliance.

Key Takeaways:

  • Kos Pharmaceuticals will present at the Deutsche Bank Small Cap Growth Conference on February 16, 2006.
  • The company's presentation will be webcast and accessible through its website at www.kospharm.com.
  • Kos is a fully integrated specialty pharmaceutical company with a focus on developing, commercializing, manufacturing, and marketing proprietary prescription products.
  • The company's principal product development strategy is to reformulate existing pharmaceutical products to improve safety, efficacy, and patient compliance.
  • Kos' product portfolio includes Niaspan, Advicor, Azmacort, Cardizem LA, Teveten, and Teveten HCT, which are used to treat various cardiovascular, metabolic, and respiratory diseases.
  • The company has a strong and growing research and development pipeline, including proprietary drug delivery technologies in solid-dose, inhalation, and aerosol metered-dose device administration.

Statistics:

  • February 16, 2006: Date of Kos' presentation at the Deutsche Bank Small Cap Growth Conference.
  • 9:30 am ET: Time of Kos' presentation on February 16, 2006.
  • 2006: Year in which the Deutsche Bank Small Cap Growth Conference is being held.
  • 15-17 February 2006: Dates of the Deutsche Bank Small Cap Growth Conference.

Sources:

  • Nigeria News and Reports
  • Kos Pharmaceuticals, Inc., Investor Relations section
  • Deutsche Bank Small Cap Growth Conference